Canadian Markets close in 4 hrs 6 mins

PharmaCyte Biotech, Inc. (PMCB)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0689-0.0019 (-2.6836%)
As of 11:29AM EDT. Market open.
People also watch
OXISAMMJCGRWAGTKSTEV
Full screen
Previous Close0.0708
Open0.0670
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0650 - 0.0700
52 Week Range0.0200 - 0.1700
Volume318,397
Avg. Volume1,717,506
Market Cap67.05M
Beta3.06
PE Ratio (TTM)-6.89
EPS (TTM)-0.01
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire8 days ago

    PharmaCyte Biotech Appoints Alan Morell of Creative Management Partners as Strategic Advisor

    PharmaCyte Biotech, Inc. , a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced the appointment of Alan Morell, the Chairman and Chief Executive Officer of Creative Management Partners, as a Strategic Advisor to the Chief Executive Officer and Board of ...

  • Business Wire15 days ago

    PharmaCyte Restructures Agreements with Austrianova to Strengthen Partnership

    PharmaCyte Biotech, Inc. , a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it has reached an agreement with Austrianova to restructure certain agreements between them pursuant to a Binding Term Sheet .

  • ACCESSWIRE16 days ago

    MicroCap Review Magazine Fall 2017 Issue Now Available

    The Digital Issue of the Fall 2017 MicroCap Review Magazine, The Official Magazine for the MicroCap Stock Market, can be read on www.StockNewsNow.com LOS ANGELES, CA / ACCESSWIRE / September 5, 2017 / ...